The Kable

The Kable

Share this post

The Kable
The Kable
💉 AstraZeneca invests in rare diseases; Novartis hopes to take the STING out; Merck bets on smart biologics
Friday Kable

💉 AstraZeneca invests in rare diseases; Novartis hopes to take the STING out; Merck bets on smart biologics

#508 | Bird flu jumps species; Ending the gender gap in wifi; Milk for diabetes

Vinod's avatar
Vinod
Mar 15, 2024
∙ Paid

Share this post

The Kable
The Kable
💉 AstraZeneca invests in rare diseases; Novartis hopes to take the STING out; Merck bets on smart biologics
1
Share

Hello, and welcome back to a relatively light week in the life sciences.

A week where the south Indian state of Kerala witnessed an outbreak of mumps with 190 cases being reported in a single day.

Also a week where researchers learned how to use AI to identify emerging Covid variants. Oh, you thought Covid was over, didn't you?

In what could be seen as a r…

Keep reading with a 7-day free trial

Subscribe to The Kable to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 The Kable
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share